Akari Therapeutics, Statistics
Total Valuation
AKTX has a market cap or net worth of $14.14 million. The enterprise value is $12.11 million.
| Market Cap | 14.14M |
| Enterprise Value | 12.11M |
Important Dates
The next estimated earnings date is Tuesday, August 18, 2026, after market close.
| Earnings Date | Aug 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AKTX has 1.75 million shares outstanding. The number of shares has increased by 143.97% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.75M |
| Shares Change (YoY) | +143.97% |
| Shares Change (QoQ) | +37.44% |
| Owned by Insiders (%) | 32.15% |
| Owned by Institutions (%) | 3.45% |
| Float | 1.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.64 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.27, with a Debt / Equity ratio of 0.05.
| Current Ratio | 0.27 |
| Quick Ratio | 0.21 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -30.90 |
Financial Efficiency
Return on equity (ROE) is -155.28% and return on invested capital (ROIC) is -39.40%.
| Return on Equity (ROE) | -155.28% |
| Return on Assets (ROA) | -17.97% |
| Return on Invested Capital (ROIC) | -39.40% |
| Return on Capital Employed (ROCE) | -144.12% |
| Weighted Average Cost of Capital (WACC) | 16.37% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.67M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.86M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.74% in the last 52 weeks. The beta is 1.39, so AKTX's price volatility has been higher than the market average.
| Beta (5Y) | 1.39 |
| 52-Week Price Change | -79.74% |
| 50-Day Moving Average | 11.88 |
| 200-Day Moving Average | 11.87 |
| Relative Strength Index (RSI) | 40.05 |
| Average Volume (20 Days) | 37,208 |
Short Selling Information
The latest short interest is 16,430, so 1.79% of the outstanding shares have been sold short.
| Short Interest | 16,430 |
| Short Previous Month | 17,997 |
| Short % of Shares Out | 1.79% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.17 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -12.20M |
| Pretax Income | -29.91M |
| Net Income | -28.05M |
| EBITDA | -29.51M |
| EBIT | -29.51M |
| Earnings Per Share (EPS) | -$26.91 |
Balance Sheet
The company has $2.77 million in cash and $732,000 in debt, with a net cash position of $2.04 million or $1.16 per share.
| Cash & Cash Equivalents | 2.77M |
| Total Debt | 732,000 |
| Net Cash | 2.04M |
| Net Cash Per Share | $1.16 |
| Equity (Book Value) | 14.38M |
| Book Value Per Share | 12.56 |
| Working Capital | -9.83M |
Cash Flow
| Operating Cash Flow | -10.91M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 1.43M |
| Free Cash Flow | -10.91M |
| FCF Per Share | -$6.23 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AKTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -143.97% |
| Shareholder Yield | -143.97% |
| Earnings Yield | -198.31% |
| FCF Yield | -77.11% |
Analyst Forecast
The average price target for AKTX is $28.39, which is 251.36% higher than the current price. The consensus rating is "Buy".
| Price Target | $28.39 |
| Price Target Difference | 251.36% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 31, 2026. It was a reverse split with a ratio of 1:40.
| Last Split Date | Mar 31, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:40 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |